Free shipping on all orders over $ 500

Degarelix (GSK1278863)

Cat. No. M10250

All AbMole products are for research use only, cannot be used for human consumption.

Degarelix (GSK1278863) Structure
Synonym:

FE-200486; GSK1278863

Size Price Availability Quantity
1mg USD 60  USD60 In stock
5mg USD 160  USD160 In stock
10mg USD 270  USD270 In stock
25mg USD 440  USD440 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Degarelix (GSK1278863) is a competitive and reversible gonadotropin-releasing hormone receptor (GnRHR) antagonist. Degarelix directly acts on the pituitary receptors to luteinizing hormone-releasing hormone (LHRH), preventing the effect of endogenous LHRH. The use of degarelix eliminates the undesirable surge of initial gonadotropin and testosterone levels produced by LHRH agonists. With the exception of PC-3 cells, Degarelix treatment reduces the cell viability of all prostate cell lines (WPE1-NA22, WPMY-1, BPH-1 cells, VCaP cells). GnRH antagonist degarelix has a direct effect on the growth of prostate cells through apoptosis. Degarelix (0.3 to 10 μg/kg) in rats produces a dose-dependent suppression of the pituitary-gonadal axis as revealed by the decrease in plasma luteinizing hormone (LH) and testosterone levels.

Chemical Information
Molecular Weight 1632.26
Formula C82H103ClN18O16
CAS Number 214766-78-6
Solubility (25°C) DMSO 10 mg/mL
Water 5 mg/mL (ultrasonic and warming)
Storage -20°C, dry, sealed
References

[1] Monica Sakai, et al. PLoS One. In search of the molecular mechanisms mediating the inhibitory effect of the GnRH antagonist degarelix on human prostate cell growth

[2] Ferenc G Rick, et al. Onco Targets Ther. An update on the use of degarelix in the treatment of advanced hormone-dependent prostate cancer

[3] Anders Sonesson, et al. Drug Metab Dispos. Metabolite profiles of degarelix, a new gonadotropin-releasing hormone receptor antagonist, in rat, dog, and monkey

[4] Pierre Broqua, et al. J Pharmacol Exp Ther. Pharmacological profile of a new, potent, and long-acting gonadotropin-releasing hormone antagonist: degarelix

Related LHRH/GnRH Products
GnRH antagonist 2 

GnRH antagonist 2 (formula I) is a GnRH receptor antagonist that can be used for endometriosis research.

Kisspeptin-54(human)

Kisspeptin-54(human) (Metastin(human)) is an endogenous ligand for kisspeptin receptor (KISS1, GPR54).

Luteinizing Hormone Releasing Hormone (LH-RH), salmon

Luteinizing Hormone Releasing Hormone (LH-RH), salmon (Salmon GnRH) is the hypophysiotropic decapeptide synthesized in the hypothalamus that plays a crucial role in the control of reproductive functions.

Phoenixin-14

Phoenixin-14 (PNX-14) is one of the endogenous active isoform, and generates anxiolytic effect via the activation of the AHA GnRH system in mice.

LGnRH-III, lamprey

LGnRH-III, lamprey, an isoform of GnRH isolated from the sea lamprey, is a weak GnRH agonist with antitumor activities.

  Catalog
Abmole Inhibitor Catalog




Keywords: Degarelix (GSK1278863), FE-200486; GSK1278863 supplier, LHRH/GnRH, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.